CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 100 enrolled
Drug / intervention
Tranexamic Acid +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01248104
NCT01248104N/ACompleted
CompareCT.gov

Comparison of Tranexamic to Epsilon Aminocaproic Acid: a Prospective Analysis of Blood Conservation in Cardiac Surgery

Loma Linda University·interventional·Posted Nov 25, 2010·Updated Oct 19, 2020

In Brief

A clinical study evaluating Tranexamic Acid and Aminocaproic Acid for Cardiopulmonary Bypass. Completed, enrolled 100 participants across 1 site.

Detailed Summary

We designed a prospective double-blinded randomized trial in an attempt to detect a difference between tranexamic acid (TXA) and epsilon aminocaproic acid (EACA) in reducing transfusion in patients undergoing cardiac surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiopulmonary Bypass
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedNov 25, 2010
Enrollment StartMar 1, 2010
Primary CompletionMar 1, 2013
Study CompletionFeb 1, 2015
TodayJul 2, 2026
Enrollment to primary: 3 yearsPosted 15.6 years ago

Interventions

Tranexamic Aciddrug

Infusion during cardiac surgery

Aminocaproic Aciddrug

Infusion during cardiac surgery